Secondary analysis of electronically monitored medication adherence data for a cohort of hypertensive African-Americans

Patient Preference and Adherence

Volumn 6, Issue , 2012, Pages 207-219

  Knafl, George J ^a   Schoenthaler, Antoinette ^b   Ogedegbe, Gbenga ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptive statistical modeling; Hypertension; Medication adherence; Medication Event Monitoring System

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTRONIC MONITORING DEVICE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MEDICATION COMPLIANCE; MOTIVATIONAL INTERVIEWING; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF CONCEPT; STATISTICAL MODEL; SYSTOLIC BLOOD PRESSURE;

EID: 84876855897     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S30582     Document Type: Article

References (26)

1. Brunenberg DE, Wetzels GE, Nelemans PJ, et al. Cost effectiveness of an adherence-improving programme in hypertensive patients. Pharmacoeconomics. 2007;25:239-351.
2. Düsing R, Handrock R, Klebs S, Tousset E, Vrijens B. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE. J Hypertens. 2009;27:894-901.
3. Gerin W, Tobin JN, Schwartz JE, et al. The medication Adherence and Blood Pressure Control (ABC) trial: a multi-site randomized controlled trial in a hypertensive, multi-cultural, economically disadvantaged population. Contemp Clin Trials. 2007;28:459-471.
4. Ogedegbe G, Schoenthaler A, Richardson T, et al. An RCT of the effect of motivational interviewing on medication adherence in hypertensive African Americans: rationale and design. Contemp Clin Trials. 2007;28:169-181.
5. Rose AJ, Berlowitz DR, Manze M, Orner MB, Kressin NR. Intensifying therapy for hypertension despite suboptimal adherence. Hypertension. 2009;54:524-529.
6. Schoenthaler A, Ogedegbe G. Patients' perceptions of electronic monitoring devices affect medication adherence in hypertensive African Americans. Ann Pharmacother. 2008;42:647-652.
7. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008;336:1114-1117.
8. Sereika SM, Dunbar-Jacob J. Analysis of electronic event monitored adherence. In: Burke LE, Ockene IS, editors. Compliance in Healthcare and Research. Armonk, NY: Futura Publishing; 2003.
9. Knafl GJ, Fennie KP, Bova C, Dieckhaus K, Williams AB. Electronic monitoring device event modelling on an individual-subject basis using adaptive Poisson regression. Stat Med. 2004;23:783-801.
10. Aloia MS, Goodwin MS, Velicer WF, et al. Time series analysis of treatment adherence patterns in individuals with obstructive sleep apnea. Ann Behav Med. 2008;36:44-53.
11. Knafl GJ, Bova CA, Fennie KP, O'Malley JP, Dieckhaus KD, Williams AB. An analysis of electronically monitored adherence to antiretroviral medications. AIDS Behav. 2010;14:755-768.
12. Delucchi KL, Knafl GJ, Haug N, Sorensen J. Adaptive Poisson modeling of medication adherence among HIV-positive methadone patients provided greater understanding of behavior. In: Ekwall B, Cronquist M, editors. Micro Electro Mechanical Systems (MEMS) Technology, Fabrication Processes and Applications. Hauppauge, NY: Nova Science Publishers; 2010. Available from: https://www.novapublishers. com/catalog/product_info.php?products_id.19148. Accessed February 29, 2012.
13. Knafl GJ, Delucchi KL, Bova CA, Fennie KP, Ding K, Williams AB. A systematic approach for analyzing electronically monitored adherence data. In: Ekwall B, Cronquist M, editors. Micro Electro Mechanical Systems (MEMS) Technology, Fabrication Processes and Applications. Hauppauge, NY: Nova Science Publishers; 2010. Available from: https://www.novapublishers.com/catalog/product_info.php?products_ id.19133. Accessed February 29, 2012.
14. Ogedegbe GO, Chaplin W, Schoenthaler AS, et al. A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens. 2008;21:1137-1143.
15. Ogedegbe O, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in African-American patients. J Clin Epidemiol. 2003;56:520-529.
16. Knafl GJ, Fennie KP, O'Malley JP. Adaptive repeated measures modeling using likelihood cross-validation. In: Bovaruchuk B, editor. Proceedings Second IASTED International Conference on Computational Intelligence. Anaheim, CA: ACTA Press; 2006.
17. Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. Appl Stat. 1994;43:429-467.
18. McCullagh P, Nelder JA. Generalized Linear Models. Boca Raton, FL: Chapman & Hall/CRC; 1999.
19. Knafl GJ, Grey M. Factor analysis model evaluation through likelihood cross-validation. Stat Methods Med Res. 2007;16:77-102.
20. Stone M. An asymptotic equivalence of choice of model by crossvalidation and Akaike's criterion. J Roy Stat Soc B. 1977;39:44-47.
21. Symons MJ. Clustering criteria and multivariate normal mixtures. Biometrics. 1981;37:35-43.
22. SAS Institute Inc. SAS/STAT 9.1 User's Guide. Cary, NC: SAS Institute; 2004.
23. Takiya LN, Peterson AM, Finley RS. Meta-analysis of interventions for medication adherence to antihypertensives. Ann Pharmacother. 2004;38:617-624.
24. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288:2868-2879.
25. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.
26. Hyre AD, Krousel-Wood MA, Muntner P, Kawasaki L, DeSalvo KB. Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens. 2007;9:179-186.